NCT00674440View on ClinicalTrials.gov

Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism

PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Congenital HyperinsulinismHyperinsulinismPersistent Hyperinsulinemic Hypoglycemia of InfancyCHIPHHI
Interventions
DRUG

F-DOPA

0.08-0.16 mCi/kg once

RADIATION

PET scan

Trial Locations (1)

19104

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

lead

Children's Hospital of Philadelphia

OTHER

NCT00674440 - Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism | Biotech Hunter | Biotech Hunter